HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA interest in cosmetics hotline cools off; agency now looking at other approaches.

This article was originally published in The Rose Sheet

Executive Summary

FDA SHELVES COSMETICS ADVERSE REACTION HOTLINE after the Office of Management and Budget objected to the paperwork requirements. FDA indicated it will no longer pursue the establishment of a toll-free number for consumers to report cosmetic adverse reactions as outlined in the Nov. 10, 1994 Federal Register ("The Rose Sheet" Nov. 14, p. 1), but will continue to look at other ways to receive reports from consumers about cosmetic products.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002021

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel